Maastricht UMC+ at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Maastricht UMC+ takes part in 3 sessions at ESMO 2026 in Madrid. Its program spans lung cancer and tumours of the central nervous system, including treatment of non-small cell lung cancer with uncommon EGFR mutations such as exon 20 insertions. It also covers the modern management of cancer that has spread to the membranes around the brain and spinal cord.
| Organization | ESMO 2026 Attendance |
|---|---|
Maastricht UMC+ Maastricht, Netherlands | |
Academic hospital and university medical centre of Maastricht University in Maastricht, the Netherlands. | Chair Fri Oct 23 13:30–15:00 Rapid oral: CNS tumours Sarcoma, CNS, head & neck and rare cancers Abstract Fri Oct 23 14:42–14:52 Invited Discussant 702RO and 703RO Sarcoma, CNS, head & neck and rare cancers Satellite Sun Oct 25 13:00–14:30 Johnson & Johnson - Transforming the Treatment Journey in EGFR- Mutant NSCLC Lung & thoracic cancers Satellite Sun Oct 25 13:00–13:05 Welcome and introductions Lung & thoracic cancers Satellite Sun Oct 25 13:15–13:27 Chair Mon Oct 26 14:45–16:00 Modern management of leptomeningeal metastases Sarcoma, CNS, head & neck and rare cancers Talk Mon Oct 26 14:45–14:50 Presentation of case/condition Sarcoma, CNS, head & neck and rare cancers |
Instantly find 20 buyers from Maastricht UMC+
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction